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Rhinitis is a disease of the upper airway characterized by runny and/or blocked nose and/or sneezing. Though not viewed as a 
life threatening condition, it is also recognized to impose significant burden to the quality of life of sufferers and their caretakers and 
imposes an economic cost to society. Through a PubMed online search of the literature from 2006 to September 2011, this paper aims 
to review the published literature on rhinitis in young children below the age of 6 years. It is apparent from epidemiology studies that 
rhinitis in this age group is a relatively common problem. The condition has a heterogenous etiology with classification into allergic 
and non-allergic rhinitis. Respiratory viral infections may play a role in the pathogenesis of long standing rhinitis, but definitive studies 
are still lacking. Treatment guidelines for management are lacking for this age group, and is a significant unmet need. Although the 
consensus is that co-morbidities including otitis media with effusion, adenoidal hypertrophy and asthma, are important considerations 
of management of these children. Pharmacotherapy is limited for young children especially for those below the age of 2 years. This 
review underscores the lack of understanding of rhinitis in early childhood and therefore the need for further research in this area. 
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INTRODUCTION
Rhinitis is an inflammation of the upper airways that is 
characterised by symptoms of runny (rhinorrhea) and/or blocked 
nose and/or sneezing occurring for two or more consecutive 
days and lasting for more than an hour for most days [1, 2]. 
The Allergic Rhinitis and its Impact on Asthma (ARIA) guideline 
classifies rhinitis into allergic rhinitis (AR) and non-allergic 
rhinitis (NAR) based on the presence and absence of allergic 
sensitization. AR arises due to IgE-mediated mechanisms and 
is usually characterized with additional symptoms of itchy eyes 
(conjunctivitis). NAR has multiple possible triggers including 
infectious, hormonal, occupational, and idiopathic (previously 
termed as vasomotor rhinitis) [2]. It could well be that rhinitis in 
young children would involve both components of AR and NAR.
Rhinitis has been trivialized by clinicians as it does not cause 
fatalities, and has been understudied. More recently, however, 
rhinitis has been recognized to impose significant morbidity 
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and has a significant impact on the quality of life. It is in fact now 
considered a considerable global medical burden with a significant 
economical cost [2]. A recent paediatric survey of children 4-17 
years old conducted in the United States showed that rhinitis 
affects the quality of life (work and sleep) of sufferers and their 
caregivers [3]. Aside from the direct cost of rhinitis medications, 
rhinitis also exerts an indirect cost through its co-morbidities such 
as asthma. An example of this was illustrated by a study by Kang et 
al that rhinitis in children increased the number of outpatient and 
hospital visits of asthma sufferers [4].
Two birth cohort studies monitoring the natural history of 
childhood rhinitis [5, 6] showed a trend of increasing prevalence 
over time from infancy to adolescents. In these studies, symptoms 
of rhinitis were already observable from preschool age. Various 
others studies had also shown that rhinitis symptoms are already 
prevalent in the first 6 years of life. Except for these studies, it is our 
impression that rhinitis in early childhood is poorly characterised.
This review aims to summarize our current knowledge and to 
discuss the gaps in knowledge regarding AR in early childhood. 
Methods
Literature search was conducted using a PubMed search with 
the following key terms: ‘rhinitis’ and ‘preschool’, and filtering 
for articles in English and published 2006-2011 (n = 565 articles). 
We screen titles and abstracts of the search results for studies 
discussing rhinitis separate from other morbidities, and also for 
studies discussing subjects <6 years old separately from older 
children. The screened publications were selected based on the 
following criteria: (1) Epidemiology and risk factor analysis (n = 
45), and (2) therapeutics, intervention and management (n = 13). 
Most of the initial search results were filtered out as they focussed 
on co-morbidities such as rhinosinusitis or allergy in general. In 
addition, most of the other search results touching on rhinitis did 
not discuss children <6 years old separate from older children.
Additional information on the progression of rhinitis was 
obtained with the following key search terms: ‘rhinitis’ and 
‘natural history’ (n = 3). Additionally the search terms ‘rhinitis’ and 
‘management guidelines’ were included (n = 3).
Fig. 1 illustrates the workflow of the literature search in this 
review.
Definitions and classifications
Several large professional bodies, ARIA (World Health 
Organization), American Academy of Asthma Allergy and Clinical 
Immunology Task Force and British Society of Allergy and Clinical 
Immunology have published guidelines of the definitions, 
classification and management of rhinitis [2, 7, 8]. There is currently 
no management guidelines dedicated to children and this 
constitutes an unmet need for the clinical management of rhinitis 
in this age group. 
The definition appears to be clear cut. Rhinitis has been defined 
as a disease of the nasal lining presenting with symptoms of nasal 
itch, sneezing, runny and/or blocked nose [6-8]. The classification 
of rhinitis differs slightly between guidelines. The ARIA guideline 
separates rhinitis into allergic and non-allergic, for which NAR is 
further classified by the triggering factors into including infectious, 
hormonal, occupational, and idiopathic (previously termed as 
vasomotor rhinitis). On the other hand, the British Society for 
Allergy and Clinical Immunology has classified infectious rhinitis 
as a separate category from NAR. This classification maybe more 
appropriate for rhinitis in early childhood where infectious causes 
may play a predominant role [2, 9]. Fig. 2 is an adaptation of 
the classification of rhinitis appropriate for childhood. It is both 
clinically and epidemiologically difficult to differentiate infectious 
rhinitis from AR in young children [2, 10]. In addition, NAR may also 
be present with AR, a syndrome termed mixed allergic rhinitis, 
which may account for 50%-70% of AR cases [11].
Sinusitis often co-exists with rhinitis and the term ‘rhinosinusitis’ 
Fig. 1. The workflow of the literature review. 
*Criteria: 1. Study analyzed 
rhinitis separately from other disease conditions; 2. Study analyzes subjects 
aged 6 and below separately from subjects aged >6.apallergy.org
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has been coined to reflect this. Nasal polyps are rare in children. 
Clinical symptoms of discharge (mucopurulent), nasal obstruction, 
headache and facial pain, and ear pain and pressure are 
common symptoms of sinusitis [12]. Diagnostic confirmation 
requires endoscopic examination and CT scan of the sinuses [2]. 
Endoscopic examination is, however, difficult to perform in young 
children. Additionally CT scan examination does expose the child 
to considerable radiation [13]. Hence the diagnosis of sinusitis 
in children is quite challenging to the clinician and often has to 
depend on clinical symptoms. Additionally, most of these studies 
were not accompanied by allergy testing, hence the diagnosis 
of AR is tentative. It could well be that ‘AR symptoms’ in this age 
group may not be sufficiently sensitive for the diagnosis of AR.
Epidemiology of rhinitis in infancy and preschool age
Cross sectional studies
Most cross sectional population studies on rhinitis in early 
childhood have used the validated rhinitis questions from 
International Study of Allergy and Asthma in Childhood (ISAAC). 
However, the definitions of AR used in these studies were not 
entirely identical (Table 1). Some assessed the presence of 
symptoms indicating AR (sneezing, runny or blocked nose outside 
of cold or flu). On the other hand, other studies imposed stricter 
criteria of the requirement of diagnosis by physicians.
The prevalence of rhinitis in preschoolers 0-6 years old various 
considerably and this may be in part related to the definitions 
and age groups included in each study. The prevalence of rhinitis 
symptoms in preschool age groups ranged from 2.8% to 42.7% 
(Table 1). This wide variation in rhinitis prevalence is very similar 
to data in school aged children. The ISAAC studies which used 
the same validated questionnaire also showed a wide variation 
of rhinitis globally [14]. The studies from Singapore show that the 
prevalence of rhinitis in preschoolers is substantial with prevalence 
of 25.3% in the 4 to 6 year age group [15] and a cumulative 
prevalence of 42.7% in the 2 year age group [16]. These rates are 
in fact comparable with that reported in the phase III of the ISAAC 
with rhinitis rates reported at 25.5% for Singapore schoolchildren 
Fig. 2. Classification of etiologies of rhinitis in childhood. Non-allergic 
rhinitis with eosinophilic syndrome, occupational, drug-induced and 
hormonal removed from model due to their rarity or inapplicability in 
childhood. 
Table 1. Cross sectional studies on rhinitis in early childhood
Reference Year  Location Age group  Definition of rhinitis Prevalence
[20] 2008 China 1-6 years old  Doctor diagnosis of allergic rhinitis 3.5% of 3,945 subjects
[29] 2011 China 2-6 years old Doctor diagnosis of allergic rhinitis 2.8% of 8,819 subjects
[50] 2008 Finland 1-6 years old Yes to the question: “Does your child have allergic rhinitis?” 16.0% of 1,471 subjects
[51] 2009 Italy 3-5 years old “Rhinitis, sneezing, runny or blocked nose apart from 
colds”
Rhinitis in last 12 months:
16.8% of 1,402
Doctor diagnosed: 4.0% of 1,402
[22] 2009 Germany 5-6 years old Doctor diagnosis of allergic rhinitis (hay fever) since birth 3.9% of 606 subjects
[15] 2009 Singapore 4-6 years old  “Sneezing or a runny or blocked nose in the absence of a 
cold or a flu” 
Rhinitis: 25.3%
Rhinoconjunctivitis: 7.6%
[16] 2005 Singapore 2 years old Unspecified: validated question adopted from ISAAC Rhinitis: 42.7% of 1,026 subjects 
Rhinoconjunctivitis:
 8.4% of 1,026 subjects
[27] 2011 Thailand 3-6 years old “Sneezing, or a runny or blocked nose with no evidence of 
a cold or flu in the previous 12 months”
28% of 2,301 subjects
[52] 2009 China 3-6 years old Adopted validated questionnaire from ISAAC Nasal symptoms: 27.1%
Symptoms with skin prick test 
positive: 10.8%apallergy.org
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6-7 years old [17]. These studies indicate that the prevalence of 
rhinitis young children may be considerable.
Birth cohort studies
Birth cohort studies provide us with the opportunity to 
understand the onset and development of rhinitis (Table 2). 
Besides parental atopy, these studies have provided with 
information on environmental risk factors for the development 
of AR such as having siblings [18], environmental tobacco smoke 
exposure [19,20], traffic pollution [20]. 
The Isle of Wight birth cohort study has shown that the 
prevalence of AR continues to increase into adolescence whilst 
NAR peaks in the preschool age group and then lags behind 
AR thereafter [6]. Interestingly, gender had a distinct role where 
NAR was more common in the female gender especially in 
adolescence. A study from the Paris cohort with follow up till 18 
months has shown that the prevalence of AR-like symptoms were 
9.1% in these age groups [10].
It therefore appears that rhinitis in young children has a 
heterogenous etiology. There is a tendency to label these 
symptoms as AR; however, validation with IgE sensitization, which 
is often not studied especially in cross sectional is necessary to 
make a definitive diagnosis.
Putative risk and protective factors
Intrinsic factors such as male gender, presence of atopy markers 
(serum IgE and eosinophil count), personal history of eczema or 
wheeze and allergen sensitization are known risk factors for the 
development of AR [18, 21-25]. A study by Marinho et al. [26]also 
showed a dose-response relationship between sensitization by 
means of specific IgE and skin prick test test results in the risk of 
rhinoconjunctivitis. Parental, especially maternal, history of allergic 
symptoms is also a consistently reported risk of AR [21, 23, 27, 28].
Various environmental factors were found to increase the 
risk of rhinitis in children <6 years old. Pollution factors such as 
environmental tobacco smoke (ETS) exposure, moulds, and traffic 
pollution seem to be an important risk of rhinitis. ETS exposure 
was reported to increase the risk of rhinitis [19, 20]. However, 
this increased risk was not consistently found [18, 29]. Traffic 
related pollutions were suggested to be an adjuvant for allergen 
sensitization [30], which may explain its reported association with 
increased risk of rhinitis [30, 31]. 
Exposure to moulds and dust endotoxins in the home may be 
risk modifiers for rhinitis. A study by Codispoti et al. [18] showed 
an interesting finding that there was a bimodal shaped relation 
between dust endotoxin level and the risk of rhinitis. In this study, 
moderate levels of entotoxin concentration increased the risk of 
Table 2.  Birth cohort studies on rhinitis in early childhood
Reference Year 
Cohorts & 
locations
Age of analysis Definition of rhinitis Prevalence
[21] 2007 MAAS cohort.
Germany 
5 years old  “Sneezing or a runny or blocked nose when 
the child DID NOT have a cold or chest infec-
tion”
Rhinitis (lifetime and past 12months):
28.2% and 26.1% of 815 subjects respectively
Rhinoconjunctivitis in past 12 months: 12.1%
Doctor diagnosed rhinitis: 5.3%
[53] 2007 BAMSE cohort. 
Stockholm
4 years old “Runny or blocked nose without symptoms of 
having a cold in the last 12 months”
12%  of 2,869 subjects
[30] 2008 GINI and LISA 
cohort subjects.
Munich
4 and 6 years old “Sneezing/running/stuffed nose without a 
cold”
4 years: 10.3% of 2,696 subjects 
6 years: 15.8%% of 2,852 subjects 
[23] 2011 Swiss cohort.  4.5 years old Sneezing, runny or blocked nose, or red and 
itching eyes after contact with furry animals, 
leafing or grass in the past 12 months 
5.5% of 4,465 identified via questionnaire.
1.7% of 4,465 via doctor diagnosis.
[44] 2010 LISA cohort. 
Germany
6 years old Doctor diagnosis of allergic rhinitis 3.43% of 1,690 subjects
[10] Paris birth cohort. 18 months old Sneezing, runny or blocked nose outside 
cold/flu in the last 12 months
9.1% of 1,850 subjects
[6] 2011 Isle of Wight
UK 
 1 or 2, 4, 10 and 18 
years old
Sneezing, runny or blocked nose outside 
cold/flu in the last 12 months
Total rhinitis (1-2 years and 4 years):
15.8% and 5.4% respectively.
Only rhinitis with positive skin prick test result:
4 years: 3.4%apallergy.org
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rhinitis. However, there were protective effects against rhinitis at 
low and high levels of endotoxins instead [18]. Another study of 
the association between exposure to components of dust and 
moulds suggested a possible protective factor, though it is only 
observed in one of the two groups of subjects [32]. 
Dietary patterns may have protective effects. Several studies 
have found extended period of breastfeeding to be protective [18, 
33]. However, this protective effect was not consistently observed 
[18, 21, 23, 28]. Though the age of introduction of solid foods in 
general did not affect the risk of rhinitis [34], early introduction of 
fish into diet of infants were shown to be correlated to reduced 
risk of AR [23, 28, 33]. Interestingly a study was done to assess the 
correlation between maternal vitamin D intake during pregnancy 
and AR outcome at 5 years old where maternal vitamin D intake 
from food protected against rhinitis [35].
The role of viral infections
Respiratory virus infections have been suggested to play a 
significant role in the inception and exacerbation of asthma 
[36]. The biological link between respiratory virus infection with 
wheezing and asthma had been also been studied widely [37]. 
Birth cohort studies focused on studying asthma have shown that 
respiratory viruses are commonly detected in infants and young 
children with rhinorrhoea [38, 39]. Till date, there have not been 
published data on the role of respiratory virus on the inception of 
AR or long-term rhinitis symptoms. Regardless, the same set of 
viruses suggested related to asthma, such as human rhinovirus, 
respiratory synctitial virus, human parainfluenza virus, human 
influenza virus and human coronavirus, have been detected in 
infants with upper respiratory tract infection and rhinorrhea [40]. 
Since respiratory viruses have been shown to cause inflammatory 
changes in the upper airway as has been seen in the lower airway 
[41], it is plausible for respiratory virus infections to play a role in 
the development of AR or NAR. An ongoing birth cohort study in 
Singapore (GUSTO; http://www.gusto.sg/) will focus on this role 
of early respiratory viruses infections in development of rhinitis 
including AR.
Burden and co-morbidities
Besides its direct effect on the quality of life, rhinitis has 
significant co-morbid disorders (summarised in Fig. 3). The ARIA 
recommendations emphasizes the concept of treating upper and 
lower airway disorders as ‘one airway, one disease’ which includes 
a holistic approach towards the management of co-morbidities 
such as asthma, sinusitis, otitis media and conjunctivitis [42]. 
Adenoidal hypertrophy may be associated with AR [43]. 
Conversely adenoidal hypertrophy may mimic the symptoms of 
AR and therefore should always be considered in young children 
diagnosed with a diagnosis of AR [7]. Otitis media with effusion 
is often a co-morbidity of AR and NAR and should be evaluated 
in all young children with rhinitis. Recent onset otitis media with 
effusion in children [44] or occurring in the first 2 years of life [45] 
is associated with rhinitis at 6 years of age.
Management of rhinitis
The management of rhinitis and its co-morbidities in young 
children may require a multidisciplinary approach involving the 
paediatrician or paediatric allergist and the otolaryngologist. Fig. 
4 is a suggested management strategy for young children with 
rhinitis.
A significant unmet need lies in the pharmacological 
armamentarum that is approved for use in children less than 2 
years of age. First generation antihistamines are not recommended 
due to its sedative effect [2, 7, 8]. A second generation antihistamine, 
fexofenadine, had been tested to be safe in children 2 years old or 
older for management of AR [46] and from 6 months for chronic 
urticaria . Cetirizine and desloratidine have approval of use for AR 
in children as young as 6 months of age.
Intranasal corticosteroids such as mometasone furoate and 
mometasone diproprionate have age limit approval from 2 
years and above (with the exception for EMEA for mometasone 
diproprionate where approval is for 6 years and above). Intranasal 
application of medications may also be challenging in terms of 
the child’s co-operation with the application. In a recent study 
in Singaporean children about a quarter of children prescribed 
topical nasal medications refused to comply with therapy [47]. 
Montelukast is an additional anti-inflammatory agent that is 
approved for use for AR in children above the age of 6 months. 
Fig. 3. Relationship of rhinitis and its co-morbidities.apallergy.org
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However, a meta-analysis on very limited data in children, on 
comparative data between antihistamines, leukotriene receptor 
antagonists and intranasal corticosteroids showed that intranasal 
corticosteroids were the most effective for relief of AR [48].
Non pharmacological therapy with saline nasal rinses has also 
shown modest improvement in rhinitis symptoms in those above 
the age of 6 years [49]. 
Allergen immunotherapy is another therapeutic strategy that is 
attractive in that it reduces new sensitizations, reduces the risk of 
asthma and has a long term carry over effect even after cessation 
of therapy [2]. 
CONCLUSION 
Rhinitis in young children is common with significant 
morbidity. There are significant gaps in our knowledge in terms of 
classification and phenotyping rhinitis in this age group. There are 
many unmet needs in the management and treatment guidelines 
are lacking. The WHO ARIA guidelines currently devote only 4 
pages to childhood rhinitis in a document of 153 pages including 
references [2]. 
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